CUE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cue Biopharma Inc

Watchlist Manager

Watchlist

Price: 28 USD -8.2% Market Closed

Market Cap: $221.4m

	Cue Biopharma Inc NASDAQ:CUE	US
	Intel Corp NASDAQ:INTC	US
	SEPC Ltd NSE:SEPC	IN
	Web Travel Group Ltd ASX:WEB	AU
	Vcplus Ltd SGX:43E	MY
B	Benefit Systems SA WSE:BFT	PL
	PubMatic Inc NASDAQ:PUBM	US
E	Estrima SpA F:J79	IT
E	Eaton Corporation PLC F:3EC	IE
	Midland Exploration Inc OTC:MIDLF	CA
F	Flex Ltd BMV:FLEXN	US
F	Food Gate Trading Company CJSC SAU:9562	SA
F	Frontline Ltd NYSE:FRO	BM
	Australian Goldfields Ltd OTC:GRXXF	CA
	Valneva SE F:AYJ0	FR
	United Spirits Ltd NSE:UNITDSPR	IN
C	CapitaLand Integrated Commercial Trust F:M3T	SG
	Clariane SE PAR:CLARI	FR
	B&C Speakers SpA F:37B	IT

Profitability Summary

Cue Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-262%

Negative 3Y Average Operating Margin

-544%

Operating Margin is Increasing

-2.951% > -262%

Negative Net Margin

-436%

Negative 3Y Average Net Margin

-547%

Net Margin is Increasing

-2.897% > -436%

Negative Free Cash Flow Margin

-133%

Negative 3Y Average Free Cash Flow Margin

-422%

Free Cash Flow Margin is Increasing

-2.160% > -133%

Negative ROE

-1.603%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-488%

Declining ROIC

-353% > -1.030%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.